Common use of Identification and Labeling of Lead Extracts Clause in Contracts

Identification and Labeling of Lead Extracts. Promptly -------------------------------------------- following the conclusion of Phase II Assays on each of the Phase II Extracts, respectively, Galileo shall provide a detailed report of all Assays conducted to the Committee. Within thirty (30) days from the date of Galileo's report described above, the Committee shall meet to review the results of all of the Assays conducted up to that point and evaluate the overall progress of the Program. The Committee shall in its sole discretion label each Library Extract (or combination thereof) determined by the Committee to possess Requisite Activity as a "Lead Extract", provided, however, that in no event may more than [ ]* Extracts from Phase II be labeled as Lead Extracts without Phytera's written consent. At such time as a __________________________ * This portion of the Exhibit has been omitted pursuant to a Request for Confidential Treatment under Rule 406 of the Securities Act of 1933, as amended. The complete Exhibit, including the portions for wich confidential treatment has been requested, has been filed separately with the Securities and Exchange Commission.